Literature DB >> 16763221

A3 adenosine receptor signaling contributes to airway mucin secretion after allergen challenge.

Hays W J Young1, Chun-Xiao Sun, Christopher M Evans, Burton F Dickey, Michael R Blackburn.   

Abstract

Mucin hypersecretion is a prominent feature of obstructive airway diseases such as asthma. Clara cells conditionally produce mucin in response to inflammatory signals in a process termed mucous metaplasia. This can be followed by mucin secretion stimulated by various signaling molecules. The cellular and molecular mechanisms that regulate mucin production and secretion are not well understood. Adenosine is a signaling nucleoside that has been implicated in airway diseases in which mucus obstruction is prominent. Furthermore, the A(3) adenosine receptor (A(3)AR) is upregulated in mucin-producing goblet cells of the airway, thereby implicating it in processes involved in mucous cell biology. Here we use genetic approaches to investigate the contribution of A(3)AR signaling to mucus production and secretion in a mouse model of allergen-induced pulmonary disease. We found that the degree of mucin production in response to allergen is similar in wild-type and A(3)AR-deficient mice, and that overexpression of this receptor in Clara cells neither induces mucin production itself, nor enhances mucin production in response to allergen challenge. Collectively, these experiments demonstrate that the A(3)AR is neither necessary nor sufficient for mucous cell metaplasia. In contrast to the lack of effect on mucin production, agonist-induced mucin secretion was increased in goblet cells overexpressing the A(3)AR, and was absent in A(3)AR-deficient mice. Thus, the A(3)AR contributes to mucin secretion in allergen-induced metaplasia. Signaling through this receptor may contribute to mucus airway obstruction seen in pulmonary disorders in which adenosine levels are elevated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16763221      PMCID: PMC2643274          DOI: 10.1165/rcmb.2006-0060OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  43 in total

1.  A3 adenosine receptor signaling contributes to airway inflammation and mucus production in adenosine deaminase-deficient mice.

Authors:  Hays W J Young; Jose G Molina; Dawn Dimina; Hongyan Zhong; Marlene Jacobson; Lee-Nien L Chan; Teh-Sheng Chan; James J Lee; Michael R Blackburn
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

2.  Adenosine mediates IL-13-induced inflammation and remodeling in the lung and interacts in an IL-13-adenosine amplification pathway.

Authors:  Michael R Blackburn; Chun G Lee; Hays W J Young; Zhou Zhu; Janci L Chunn; Min Jong Kang; Suman K Banerjee; Jack A Elias
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

Review 3.  Too much of a good thing: adenosine overload in adenosine-deaminase-deficient mice.

Authors:  Michael R Blackburn
Journal:  Trends Pharmacol Sci       Date:  2003-02       Impact factor: 14.819

4.  A MARCKS-related peptide blocks mucus hypersecretion in a mouse model of asthma.

Authors:  Monique Singer; Linda D Martin; B Boris Vargaftig; Joungjoa Park; Achim D Gruber; Yuehua Li; Kenneth B Adler
Journal:  Nat Med       Date:  2004-01-11       Impact factor: 53.440

5.  Adenosine-activated mast cells induce IgE synthesis by B lymphocytes: an A2B-mediated process involving Th2 cytokines IL-4 and IL-13 with implications for asthma.

Authors:  Sergey Ryzhov; Anna E Goldstein; Anton Matafonov; Dewan Zeng; Italo Biaggioni; Igor Feoktistov
Journal:  J Immunol       Date:  2004-06-15       Impact factor: 5.422

6.  Identification of A3 receptor- and mast cell-dependent and -independent components of adenosine-mediated airway responsiveness in mice.

Authors:  Stephen L Tilley; Mindy Tsai; Cara M Williams; Z-S Wang; Christopher J Erikson; Stephen J Galli; Beverly H Koller
Journal:  J Immunol       Date:  2003-07-01       Impact factor: 5.422

7.  Activation of murine lung mast cells by the adenosine A3 receptor.

Authors:  Hongyan Zhong; Sergiy G Shlykov; Jose G Molina; Barbara M Sanborn; Marlene A Jacobson; Stephen L Tilley; Michael R Blackburn
Journal:  J Immunol       Date:  2003-07-01       Impact factor: 5.422

8.  Ca2+ dependency of 'Ca2+-independent' exocytosis in SPOC1 airway goblet cells.

Authors:  Andrea H Rossi; Patrick R Sears; C William Davis
Journal:  J Physiol       Date:  2004-06-24       Impact factor: 5.182

Review 9.  Adenosine: an endogenous regulator of innate immunity.

Authors:  György Haskó; Bruce N Cronstein
Journal:  Trends Immunol       Date:  2004-01       Impact factor: 16.687

10.  Protein kinase C-delta mediates adenosine A3 receptor-induced delayed cardioprotection in mouse.

Authors:  Ting Cun Zhao; Rakesh C Kukreja
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-07       Impact factor: 4.733

View more
  26 in total

Review 1.  The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.

Authors:  Luca Antonioli; Corrado Blandizzi; Pál Pacher; György Haskó
Journal:  Pharmacol Rev       Date:  2019-07       Impact factor: 25.468

Review 2.  Adenosine signaling and the regulation of chronic lung disease.

Authors:  Yang Zhou; Daniel J Schneider; Michael R Blackburn
Journal:  Pharmacol Ther       Date:  2009-05-05       Impact factor: 12.310

Review 3.  Adenosine receptors and asthma.

Authors:  Constance N Wilson; Ahmed Nadeem; Domenico Spina; Rachel Brown; Clive P Page; S Jamal Mustafa
Journal:  Handb Exp Pharmacol       Date:  2009

4.  Mucin production during prenatal and postnatal murine lung development.

Authors:  Michelle G Roy; Mahdis Rahmani; Jesus R Hernandez; Samantha N Alexander; Camille Ehre; Samuel B Ho; Christopher M Evans
Journal:  Am J Respir Cell Mol Biol       Date:  2011-06       Impact factor: 6.914

5.  Distribution and Cellular Uptake of PEGylated Polymeric Particles in the Lung Towards Cell-Specific Targeted Delivery.

Authors:  Tammy W Shen; Catherine A Fromen; Marc P Kai; J Christopher Luft; Tojan B Rahhal; Gregory R Robbins; Joseph M DeSimone
Journal:  Pharm Res       Date:  2015-05-23       Impact factor: 4.200

6.  Gs-coupled adenosine receptors differentially limit antigen-induced mast cell activation.

Authors:  Xiaoyang Hua; Kelly D Chason; Corey Jania; Tatiana Acosta; Catherine Ledent; Stephen L Tilley
Journal:  J Pharmacol Exp Ther       Date:  2012-11-13       Impact factor: 4.030

7.  Stimulation of lung innate immunity protects against lethal pneumococcal pneumonia in mice.

Authors:  Cecilia G Clement; Scott E Evans; Christopher M Evans; David Hawke; Ryuji Kobayashi; Paul R Reynolds; Seyed J Moghaddam; Brenton L Scott; Ernestina Melicoff; Roberto Adachi; Burton F Dickey; Michael J Tuvim
Journal:  Am J Respir Crit Care Med       Date:  2008-04-03       Impact factor: 21.405

8.  A3 adenosine receptor signaling influences pulmonary inflammation and fibrosis.

Authors:  Eva Morschl; Jose G Molina; Jonathan B Volmer; Amir Mohsenin; Ralph S Pero; Jeong-Soo Hong; Farrah Kheradmand; James J Lee; Michael R Blackburn
Journal:  Am J Respir Cell Mol Biol       Date:  2008-06-27       Impact factor: 6.914

Review 9.  Adenosine receptors as targets for therapeutic intervention in asthma and chronic obstructive pulmonary disease.

Authors:  Riccardo Polosa; Michael R Blackburn
Journal:  Trends Pharmacol Sci       Date:  2009-09-15       Impact factor: 14.819

10.  A3 and P2Y2 receptors control the recruitment of neutrophils to the lungs in a mouse model of sepsis.

Authors:  Yoshiaki Inoue; Yu Chen; Mark I Hirsh; Linda Yip; Wolfgang G Junger
Journal:  Shock       Date:  2008-08       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.